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Summary
Family 18 chitinases play key roles in organisms
ranging from bacteria to man. There is a need for spe-
cific, potent inhibitors to probe the function of these
chitinases in different organisms. Such molecules
could also provide leads for the development of che-
motherapeuticals with fungicidal, insecticidal, or anti-
inflammatory potential. Recently, two natural product
peptides, argifin and argadin, have been characterized,
which structurally mimic chitinase-chitooligosaccha-
ride interactions and inhibit a bacterial chitinase in
the nM–mM range. Here, we show that these inhibitors
also act on human and Aspergillus fumigatus chi-
tinases. The structures of these enzymes in complex
with argifin and argadin, together with mutagenesis,
fluorescence, and enzymology, reveal that subtle
changes in the binding site dramatically affect affinity
and selectivity. The data show that it may be possible
to develop specific chitinase inhibitors based on the
argifin/argadin scaffolds.
Introduction
Family 18 chitinases (CAZY GH 18 [http://afmb.cnrs-mrs.
fr/CAZY]) hydrolyze chitin, a homopolymer of N-acetyl
glucosamine. They are found in organisms ranging from
bacteria (e.g., [1]) to mammals [2, 3], where they have
diverse functions ranging from accessing chitin as an
energy resource to pathogen defense. Recent reports
have highlighted the interest in chitinase inhibitors as*Correspondence: dava@davapc1.bioch.dundee.ac.ukmolecules with chemotherapeutic potential against pa-
thogenic fungi [4], insects [5, 6], malaria transmission
[7–9], and human asthma [10]. Several different classes
of chitinase inhibitors have been reported. Allosamidin,
a pseudotrisaccharide isolated from Streptomyces, is
the most characterized of these and inhibits family 18
chitinases in the nM range [11, 12]. A wealth of struc-
tural information is available demonstrating how this
natural product binds to family 18 chitinases [13–17].
Unfortunately, allosamidin is no longer commercially
available and total synthesis is complicated [18]. Cyclic
proline-containing dipeptides have also been reported
as chitinase inhibitors, although the most potent of these
currently only inhibit in the high M range [19–22].
Recently, a novel class of natural product chitinase
inhibitors has been reported. Two cyclic pentapeptides,
argifin [5] and argadin [6] (Figure 1), were isolated from
Gliocladium and Clonostachys fungal cultures, respec-
tively. Initial tests against an insect chitinase from the
blowfly Lucilia cuprina revealed that argifin and argadin
inhibited the enzyme with surprisingly low IC50 values in
the nanomolar range, respectively [5, 6]. A subsequent
structural study revealed the binding mode of argifin
and argadin to chitinase B of the soil bacterium Serratia
marcescens, showing that these peptides precisely
mimicked the interaction between substrate (i.e., chitin/
chitooligosaccharides) and the protein. Argifin/argadin
appeared to occupy sugar subsites −1, +1, +2 (stan-
dard glycosidase nomenclature, with the scissile bond
between the −1 and +1 subsites [23]), whereas allosam-
idin binds to the −3, −2, −1 subsites [13–16]. Serratia
marcescens chitinase B (SmChiB) belongs to a sub-
class of chitinases known as the “bacterial” class of
chitinases [4, 24] which, apart from a catalytic core
based on a (βα)8 fold, contain a separate α/β domain
that gives the active site a deep, almost tunnel-like
character [14, 25] toward the +1, +2 subsites. In con-
trast, chitinases of the “plant” class (e.g., hevamine
from Hevea brasiliensis [13]) contain the (βα)8 catalytic
core only, with a fully exposed active site and no well-
defined +1, +2 subsites.
The opportunistic fungal pathogen Aspergillus fumi-
gatus produces a wide range of chitinolytic enzymes
including family 18 chitinases of both the bacterial and
plant classes. The secreted ChiB1 chitinase (AfChiB1)
is the major, inducible member of the former class [26],
and in this study we investigate the effects of argifin
and argadin on AfChiB1 and a human bacterial-class
chitinase (chitotriosidase; HCHT). Our aim is to deter-
mine whether these cyclopentapeptides or their deriva-
tives are suitable scaffolds for further optimization to
selectively inhibit specific target chitinases. A combina-
tion of X-ray crystallography, mutagenesis, enzymol-
ogy, and ligand binding studies is used to probe the
key contributions and differences in binding in context
of high-resolution crystal structures of the AfChiB1/
HCHT argifin/argadin complexes. Despite high se-
quence conservation in the vicinity of the active site,
affinity for argifin/argadin differs significantly between
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aFigure 1. Chemical Structures of Argifin and Argadin
s
The 2D chemical structures, with configuration of stereocenters as
cdefined through a combination of spectroscopic analyses [5, 6] and
TX-ray crystallography [37], are shown. The individual amino acid
moieties are numbered to allow crossreferencing with Table 1. c
[
dthese chitinases and could be exploited for the design a
of specific argifin/argadin derivatives in the future. t
n
(Results
a
(AfChiB1 Structure
The major secreted chitinase of Aspergillus fumigatus, o
aAfChiB1, was cloned and overexpressed as a GST fu-
sion protein in E. coli. Following purification and cleav- A
hage of the GST, full-length AfChiB1 was crystallized
using Li2SO4 solutions. Synchrotron diffraction data N
acollected to 1.7 Å resolution (see Supplemental Table
S1) were used to solve the structure by molecular re- m
aplacement, followed by refinement, which yielded a fi-
nal model with an R factor of 0.180 (Rfree = 0.200) (Table p
dS1). The AfChiB1 structure represents the second ex-
ample of a fungal chitinase structure, the first one being A
tCTS1 from Coccidioides immitis (CiCTS1), for which
both an unliganded structure and an inhibitor complex a
gwith allosamidin have been determined [15, 27].
AfChiB1 is 66% identical in sequence to CiCTS1, with W
pno insertions or deletions. The structures are similar,
with an rmsd of 0.7 Å on Cα atoms. AfChiB1 contains a
aa (βα)8 fold but lacks helix α1 (Figure 2), in common
with other proteins from the family 18 chitinase family s
s[27–29]. Asp175 and Glu177 at the end of β4 form part
of the family 18 chitinase DxE motif (see CAZY [http:// A
wafmb.cnrs-mrs.fr/CAZY]), with Glu177 as the catalyticcid. A path of solvent-exposed aromatic residues runs
hrough the active-site cleft (Figure 2). Mutagenesis and
rystallographic studies have shown that these side
hains play a key role in substrate/inhibitor binding [15,
0–32].
Although AfChiB1 was crystallized in the absence of
ny substrate/inhibitor and was not cryoprotected with
rganic solvent, well-defined density for a small mole-
ule was found in the active site (Figure 2B). A Tris
olecule present in the protein buffer was found to fit
his density and was included in further refinement. Tris
as five hydrogen bonds to active site residues, all of
hich, with the exception of Asp246, are conserved in
amily 18 chitinases. The catalytic acid Glu177, presum-
bly deprotonated, hydrogen bonds the Tris amine and
ne of the hydroxyls, whereas Tyr245, which is thought
o participate in transition-state stabilization [15, 21, 31,
3], hydrogen bonds another hydroxyl (Figure 2B). Al-
hough, to our knowledge, this is the first report of Tris
inding to a family 18 chitinase active site, Tris has
een previously described as binding to and/or inhibit-
ng other glycoside hydrolases [34–36].
tructures of AfChiB1 and HCHT
ith Argifin and Argadin
rgifin was soaked into AfChiB1 crystals, synchrotron
ata were collected, and the AfChiB1-argifin complex
as refined to 2.0 Å resolution (Table S1). Argifin was
lso cocrystallized with the human chitotriosidase (HCHT),
ynchrotron data were collected, and the HCHT-argifin
omplex was refined to 1.65 Å resolution (Table S1).
he AfChiB1-argifin and HCHT-argifin complexes are
ompared to the published SmChiB-argifin complex
37] in Figure 3, and a quantitative comparison of hy-
rogen bonding contacts is shown in Table 1. Argifin
ppears to bind the three different family 18 chitinases
hrough residues that are mostly conserved. The gua-
yl-urea moiety stacks on a conserved tryptophan
Trp384 in AfChiB1) and interacts with the glutamate
nd aspartate from the family 18 chitinase DxE motif
Glu177 and Asp175 in AfChiB1, respectively). On the
pposite side of the active site, the guanyl-urea moiety
lso interacts with a conserved tyrosine (Tyr245 in
fChiB1), while only AfChiB1 establishes a significant
ydrogen bond from the conserved Asp246. The argifin
-methylphenylalanine is sandwiched between two
romatic residues (Trp137 and Phe251 in AfChiB1). Al-
ost all bacterial-type chitinases have two tryptophans
t these positions; however, AfChiB1 unusually has a
henylalanine at position 251. Apart from a further hy-
rogen bond to a conserved arginine (Arg301 in
fChiB1), there are no other direct hydrogen bonds be-
ween the three chitinases and argifin. In SmChiB, only
n extended loop (near Asp316) closely packs with ar-
ifin, but no favorable interactions are established.
hile argifin binds to AfChiB1 and HCHT in a similar
osition and orientation (maximum coordinate shift in
rgifin backbone after superposition of the AfChiB1
nd HCHT proteins is 0.6 Å), it seems to be significantly
hifted in the SmChiB complex (maximum coordinate
hift in argifin backbone after superposition of the
fChiB1/HCHT and SmChiB proteins is 1.9 Å). Thus,
ith the exception of AfChiB1 Phe251 and SmChiB
Natural Product Chitinase Inhibitors
67Figure 2. Structure of AfChiB1
(A) Stereo figure of the AfChiB1 fold, shown as a ribbon drawing. Solvent-exposed aromatic residues are shown with green carbon atoms.
The Glu177 and Asp175 from the family 18 chitinase DxE motif are shown with orange carbon atoms. The ordered Tris molecule in the active
site is shown with magenta carbon atoms.
(B) Stereo figure of the AfChiB1 active site identifying the key residues and showing an unbiased rFor − rFcr, fcalc electron density map (2.5σ,
cyan) together with a Tris molecule (magenta carbon atoms). Hydrogen bonds between AfChiB1 residues and Tris are shown as green
dashed lines.Asp316, the residues directly contacting argifin are con-
served in the three chitinases studied here, although
some differential contacts are made through water-
mediated hydrogen bonds (Figure 3; Table 1).
Crystal structures of argadin complexed to both
AfChiB1 (to 1.85 Å resolution) and HCHT (to 1.75 Å res-
olution) were also refined (Table S1). The AfChiB1-
argadin and HCHT-argadin complexes are compared to
the published SmChiB-argadin complex in Figure 4,
and a quantitative comparison of hydrogen bonding
contacts is shown in Table 1. Argadin binds the three
chitinases in a similar orientation and position, although
the inhibitor sits somewhat deeper into the active site
in the HCHT complex (maximum shift of equivalent
atoms in argadin after superposition of the three pro-
teins is 1.1 Å). The cyclized aspartic β-semialdehyde
stacks with the same conserved tryptophan (Trp384 in
AfChiB1) as the argifin guanyl-urea moiety (Figure 4).This interaction is reminiscent of the observed stacking
with a GlcNAc pyranose in chitinase-substrate com-
plexes [30, 31, 37]. The argadin histidine side chain
penetrates the active site to establish contacts with the
DxE motif. Intriguingly, the histidine backbone oxygen
approaches the catalytic glutamate to within 3 Å resolu-
tion (Figure 4). Given the pH of the crystallization buffer
and the enzyme assays, these atoms would both be
deprotonated, and no hydrogen bond could form. How-
ever, Glu177 is the catalytic acid, i.e., the residue that
protonates the scissile glycosidic bond. It may well be
that the pKa of this residue is tuned by its surroundings
so that it is protonated near neutral pH, and thus an
additional hydrogen bond may well exist to the argadin
histidine backbone oxygen. On the opposite side of the
active site, a conserved cluster of residues (Tyr245,
Asp246, and Arg301 in AfChiB1) establishes three hy-
drogen bonds observed in all three chitinase-argadin
Chemistry & Biology
68Figure 3. Comparison of Argifin Binding to Family 18 Chitinases
The crystal structures of argifin (magenta carbon atoms) in complex with AfChiB1, HCHT, and SmChiB are shown as a transparent surface
(left column) or sticks (right column) representations in two different orientations. Unbiased rFor − rFcr, fcalc electron density maps, used for
building the initial inhibitor models, are shown in cyan, contoured at 2.5σ. Hydrogen bonds with a WHAT IF HB2 score > 0.3 (see Table 1) are
shown as green dashed lines. Water molecules involved in water-mediated protein-ligand hydrogen bonds (Table 1) are shown as orange
spheres (in the sticks images only). Protein side chains shown are those within a WHAT IF [60] contact distance of 0.75 Å from the ligand.complexes (Figure 4; Table 1). Interestingly, in all three t
Tcomplexes, two water molecules are observed at
equivalent positions mediating hydrogen bonds be- aween argadin and the protein backbone (AfChiB1
rp137 and Asp246). The argadin Nω-acetylarginine and
minoadipic acid side chains are aligned side to side
Natural Product Chitinase Inhibitors
69Table 1. Details of Argifin Binding to Family 18 Chitinases
Argifin
AfChiB1 HCHT SmChiB
Binding/inhibition (M) Kd = 0.46/IC50=1.1 IC50 = 4.5 Ki = 33
Buried surface (Å2) 112 121 133
Internal energy (kJ/mol) −212 −211 −199
H bonds (protein)
3,Oδ1 W137,N1 (0.80) W99,N1 (0.77) W97,N1 (0.74)
1,Oι1 Y245,Oη (0.66) Y212,Oη (0.72) Y214,Oη (0.72)
1,O R301,Nη1 (0.16)
1,O R301,Nη2 (0.44) R294,Nη2 (0.31)
1,Nι2 D175,Oδ2 (0.55) D138,Oδ2 (0.51) D142,Oδ2 (0.46)
1,Nι2 E177,O2 (0.37) E140,O2 (0.33) E144,O2 (0.33)
1,Nη1 E177,O2 (0.70) E140,O2 (0.62) E144,O2 (0.68)
1,Nη2 D246,Oδ2 (0.53) D213,Oδ2 (0.23)
1,N E177,O1 (0.71) E140,O1 (0.81) E144,O1 (0.67)
H bonds (water)
3,Oδ1 W1971 (0.68)
4,Oδ1 W2369 (0.77)
4,Oδ1 W2448 (0.64)
4,Oδ1 W2677 (0.45)
4,O W3067 (0.67)
1,Nη2 W2085 (0.14) W48 (0.69) W1551 (0.73)
5,N W73 (0.59)
H bonds (internal)
1,Oι1 1,Nη2 (0.54) 1,Nη2 (0.57) 1,Nη2 (0.57)
5,O 3,N (0.70) 3,N (0.78) 3,N (0.75)
Argadin
Binding/inhibition (M) Kd = 0.81/IC50=0.5 IC50 = 0.013 Ki = 0.020
Buried surface (Å2) 130 138 148
Internal energy (kJ/mol) −107 −133 −81
H bonds (protein)
3,O R301,Nη1 (0.40) R269,Nη1 (0.27)
3,O R301,Nη2 (0.64) R269,Nη2 (0.54) R294,Nη2 (0.70)
5,Oδ1 R301,Nη2 (0.29) R269,Nη2 (0.31)
5,Oδ1 D246,Oδ2 (0.67) D213,Oδ2 (0.54) D215,Oδ2 (0.64)
1,N2 D175,Oδ2 (0.73) D138,Oδ2 (0.78) D142,Oδ2 (0.77)
1,Nδ1 Y245,Oη (0.87) Y212,Oη (0.88) Y214,Oη (0.76)
H bonds (water)
5,Oδ1 W1131 (0.80)
2,Oζ1 W2232 (0.77) W1078 (0.73) W1502 (0.69)
2,Oζ1 W1157 (0.58)
1,O W2250 (0.32)
2,O W1059 (0.59)
H bonds (internal)
2,Oζ1 3,Nη1 (0.69) 3,Nη1 (0.88) 3,Nη1 (0.79)
3,Oι1 3,Nη2 (0.57) 3,Nη2 (0.57) 3,Nη2 (0.51)
2,Oζ2 3,N (0.75) 3,N (0.94) 3,N (0.86)
2,Oζ2 3,N (0.62) 3,N (0.69) 3,N (0.78)
2,O 5,N (0.43) 5,N (0.41) 5,N (0.20)
5,Oδ1 2,N (0.79) 2,N (0.85) 2,N (0.79)
Argifin/argadin internal energy was calculated with the GROMACS force field using standard parameters [64]. Buried surface was calculated
with WHAT IF [60]. Hydrogen-bond geometry is expressed with the WHAT IF HB2 score, ranging from 0.0 (no hydrogen bond) to 1.0 (perfect
hydrogen bond), which includes information on distances and angles [60, 65]. Hydrogen bonds < 0.3 are considered to be weak and are not
shown in Figures 3 and 4. Argifin/argadin atoms are identified by side chain number (see Figure 1) and standard amino acid nomenclature.through two strong intramolecular hydrogen bonds (Ta-
ble 1), forming a flat surface rich in π-electrons, in-
teracting with the two aromatic residues that line the
binding cleft (Trp137 and Phe251 in AfChiB1). On the
other end of the argadin molecule, the proline side
chain does not appear to make specific contacts with
the protein.
Enzymology
Binding of argifin and argadin to Serratia marcescens
chitinase B (SmChiB) was previously investigated [37],and it was shown that argadin is a potent inhibitor with
a Ki of 0.020 M, whereas argifin is a three orders of
magnitude weaker inhibitor with a Ki of 33 M (Table
1). We have investigated the binding of these inhibitors
to AfChiB1, a range of AfChiB1 mutants, and the human
chitotriosidase. To conserve the (no longer available)
stocks of argifin and argadin, we have used intrinsic
tryptophan fluorescence as a direct approach to meas-
uring AfChiB1 affinity rather than inhibition. Titration of
increasing amounts of inhibitor leads to quenching of
protein tryptophan fluorescence, which can be fitted to
Chemistry & Biology
70Figure 4. Comparison of Argadin Binding to Family 18 Chitinases
The crystal structures of argadin (magenta carbon atoms) in complex with AfChiB1, HCHT, and SmChiB are shown as transparent surface
(left column) or sticks (right column) representations in two different orientations. Unbiased rFor − rFcr, fcalc electron density maps, used for
building the initial inhibitor models, are shown in cyan, contoured at 2.5σ. Hydrogen bonds with a WHAT IF HB2 score > 0.3 (see Table 1) are
shown as green dashed lines. Water molecules involved in water-mediated protein-ligand hydrogen bonds (Table 1) are shown as orange
spheres (in the sticks images only). Protein side chains shown are those within a WHAT IF [60] contact distance of 0.75 Å from the ligand.a standard Langmuir binding isotherm for a single bind- w
ting site, allowing the direct calculation of the dissoci-
ation constant K (Figure 5). Surprisingly, argifin binds 1dith a Kd of 0.46 M, two orders of magnitude tighter
han observed for the SmChiB-argifin interaction (Table
). Furthermore, argadin, which for SmChiB was the
Natural Product Chitinase Inhibitors
71tightest inhibitor of the two, binds AfChiB1 with a Kd of
only 0.81 M, approximately 40-fold weaker compared
to SmChiB (Table 1). To validate the tryptophan fluores-
cence approach, IC50 for argifin/argadin inhibition of
AfChiB1 were also determined (using a standard en-
zyme assay with 4-methylumbelliferyl-derived substrate
analogs), which appeared to be similar to the Kds
derived with tryptophan fluorescence (Table 1). HCHT
inhibition was also measured with standard dose-
response enzyme-activity curves. Similar to the shift
observed for AfChiB1, argifin inhibition of HCHT (IC50 =
4.5 M) is increased an order of magnitude compared
to SmChiB (Table 1). However, argadin is a low nM in-
hibitor of HCHT (IC50 = 0.013 M), similar to SmChiB.
The structures of the AfChiB1, HCHT, and SmChiB chi-
tinases in complex with the inhibitors allow an inter-
pretation of these differences in binding and inhibition.
There are a number of features in the AfChiB1-argifin
complex that explain why argifin is a 1 to 2 orders of
magnitude better inhibitor for AfChiB1 than for the
other two chitinases. First, Trp384, which is conserved
in all family 18 chitinases, is able to adopt a different
conformation to maximize the amount of stacking with
argifin’s guanyl-urea moiety (Figure 3). In AfChiB1, 20.2
Å2 of this tryptophan is buried by the inhibitor, com-
pared to 18.9 Å2 and 17.4 Å2 in the HCHT and SmChiB
complexes, respectively. Second, AfChiB1 is the only
one of the three chitinases to make a significant hy-
drogen bond through the conserved Asp246 (Table 1;
Figure 3) and contains the largest number of direct and
water-mediated protein-inhibitor hydrogen bonds (14,
compared to 9 for both the HCHT and SmChiB argifin
complexes). The structures also explain why SmChiB
interacts relatively poorly with argifin. Although SmChiB
buries the largest amount of surface upon argifin bind-
ing (Table 1), it does so through a number of unfavor-
able interactions, which shift the inhibitor’s position in
the active site (Figure 3) and force it into a less favor-
able conformation as assessed by calculated potential
energy and intramolecular hydrogen bond geometry
(Table 1). SmChiB possesses a large loop, with Asp316
at its tip, which folds over the active site, giving it a
tunnel rather than a groove character (Figure 3) [14, 30].
Asp316 is pushed into the inhibitor, with both of its ter-
minal oxygens sterically clashing with argifin’s phenyl-Table 2. Details of Enzymology and Ligand Binding on Wild-Type and Mutant AfChiB1
Mutant Km (M) Vmax (M/s) kcat (s−1) kcat/Km (M−1s−1) Argifin Kd (M) Argadin Kd (M)
WT 19.9 ± 2.8 0.0032 ± 0.0002 1.6 ± 0.1 0.08 0.46 ± 0.06 0.81 ± 0.10
D175A ND ND ND ND 3.81 ± 0.31 3.60 ± 0.50
E177A ND ND ND ND ND ND
Y245F 28.8 ± 10.7 0.00007 ± 0.00001 0.035 ± 0.005 0.001 ND 5.57 ± 0.45
D246A 16.2 ± 8.8 0.00007 ± 0.00001 0.035 ± 0.005 0.002 ND ND
R301K 34.3 ± 7.1 0.0002 ± 0.00002 0.1 ± 0.01 0.003 2.16 ± 0.09 1.02 ± 0.55
W137A 36.4 ± 9.6 0.0003 ± 0.00004 0.15 ± 0.02 0.004 ND ND
A217G 8.4 ± 1.8 0.0002 ± 0.00001 0.1 ± 0.005 0.01 4.24 ± 1.15 2.84 ± 0.23
M243A 31.9 ± 6.9 0.0002 ± 0.00002 0.1 ± 0.01 0.003 1.73 ± 0.21 9.39 ± 2.04
F251A ND ND ND ND ND ND
T138A 10.7 ± 1.3 0.0015 ± 0.00006 0.75 ± 0.03 0.07 1.21 ± 0.13 3.04 ± 0.80
E322A 6.3 ± 1.1 0.0020 ± 0.00008 1.0 ± 0.04 0.2 1.37 ± 0.15 2.93 ± 0.26
All experiments were performed in triplicate, with the exception of Y245F kinetics and T138A-argadin tryptophan fluorescence, which were
performed in duplicate. ND, no significant signal. The mutants are divided into three different groups, as explained in the Discussion.alanine (distances of 2.7 and 2.9 Å to the backbone
oxygen and N-methyl group, respectively).
Analysis of the chitinase-argadin complexes also ex-
plains why argadin binds to HCHT and SmChiB with
similar (low nM) affinity but remarkably 40-fold weaker
to AfChiB1 (Table 1). Although argadin interacts with
the three chitinases through almost identical hydrogen
bonds (i.e., Asp175, Tyr245, Asp246, and Arg301 in
AfChiB1), even including two “conserved” water mole-
cules (Figure 4; Table 1), there is a crucial difference in
stacking interactions. Phe251 in AfChiB1 (a tryptophan
in HCHT and SmChiB; Figure 4) is unusual in that out
of 208 bacterial-type family 18 chitinases available as
a sequence alignment in the SMART database [38],
only 10 possess a phenylalanine at this position, and
the others almost without exception have a tryptophan.
While this may initially seem a rather conservative sub-
stitution, there are several reports showing that the res-
idue at this position is essential for ligand/substrate
binding. Mutation of the equivalent Trp220 in SmChiB
to alanine reduces the affinity for argifin only 12-fold,
but the affinity for argadin is reduced 250-fold [37].
Similarly, mutation of this tryptophan in another chi-
tinase shows a significant reduction in activity [32, 39].
Surface calculations with WHAT IF show that argadin
stacks with 12.9 Å2 contact surface onto Phe251 in the
AfChiB1 complex, whereas it buries 15.0 Å2 and 17.7
Å2 on the tryptophans Trp218 and Trp220 in the HCHT
and SmChiB complexes, respectively. It has been esti-
mated that burial of hydrophobic surface contributes to
free energy of binding with G = 15 cal mol−1 A−2 [40,
41], and this does not take into account possible further
favorable contributions from π-π stacking as observed
here, in particular for argadin (Figure 4). Thus, the 2.1–
4.8 Å2 extra buried surface on the tryptophans in the
HCHT and SmChiB complexes compared to the
Phe251 in AfChiB1 could contribute to the 40-fold dif-
ference in affinity.
To further establish the contributions of individual
residues to affinity and selectivity of AfChiB1 for argifin
and argadin, we have individually mutated every resi-
due that is seen to contact either inhibitor in the com-
plexes with AfChiB1, with the exception of Trp384 and
Tyr48 (Figures 3 and 4). These mutants were then sub-
jected to kinetic analyses using fluorescent substrates
Chemistry & Biology
72and inhibitor binding experiments using tryptophan flu- a
aorescence, the results of which are shown in Table 2
and Figure 5. Based on these data and the structures A
iof the inhibitor complexes, the mutants can be divided
into three groups. t
sThe first group concerns Asp175, Glu177, Tyr245,
Asp246, and Arg301. These residues make direct hy- b
rdrogen bonds to argifin/argadin (Figures 3 and 4 and
Table 1) and also interact with substrate in the known f
vchitinase-substrate complexes [13, 30, 31, 33]. Mut-
ations of these residues reduce kcat by 1 to 2 orders of b
(magnitude, while no large effects on Km are observed
(Table 2). This suggests that these residues are crucial
Afor catalysis rather than substrate binding, mostly in
agreement with mutational studies of these residues in v
aother family 18 chitinases [14, 15, 31, 33, 42]. Interest-
ingly, however, there are significant effects on argifin/ (
Nargadin binding (with the exception of Arg301Lys-Figure 5. Kinetics and Inhibition
(A) Quenching of intrinsic AfChiB1 protein tryptophan fluorescence measured at increasing argifin concentrations. Third degree polynomials
were fitted to the observed spectra. These were used to determine total fluorescence at 340 nm, plotted as fraction of maximum fluorescence
in (B) and (C).
(B and C) Dose-response curves of fractional tryptophan fluorescence at 340 nm versus argifin (B) or argadin (C) concentration for wild-type
and mutant AfChiB1. All data points represent the average of three measurements ± standard deviation (except for the T138A-argadin data,
which were measured in duplicate). Data were fitted against a single binding site equation F/Fmax= (C*[L])/(Kd + [L]), where C is the capacity
and [L] is the ligand concentration. Calculated Kds are shown in Table 2.
(D) Initial velocity measured at different substrate concentrations for wild-type and mutant AfChiB1. All data points represent the average of
three measurements ± standard deviation (except for the Y245F data, which were measured in duplicate). Data were fitted against the
Michaelis-Menten equation v = (Vmax*[S])/(Km + [S]), with the results shown in Table 2.rgadin), ranging from 4-fold reduction (Asp175Ala-
rgadin) to no detectable binding (Glu177, Tyr245, and
sp246). This demonstrates that all the hydrogen bond-
ng contacts observed in the complexes make key con-
ributions to affinity. There are two mutants that show
ignificant differential effects on argifin versus argadin
inding. While the Tyr245Phe mutation completely ab-
ogates binding to argifin, a 7-fold reduction in affinity
or argadin is observed (Table 2). Similarly, the conser-
ative Arg301Lys substitution appears to affect argifin
inding (5-fold reduction) more than argadin binding
no reduction).
The second group of mutants concerns Trp137,
la217, Met243, and Phe251. These residues are in-
olved in hydrophobic contacts with the substrate/re-
ction intermediate by stacking with the substrate
Trp137/Phe251 equivalents) or forming a pocket for the
-methylcarbamoyl group (Ala217/Met243 equivalents)
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73[13, 30, 31, 43]. The Trp137Ala and Phe251Ala mu-
tations both affect substrate binding and/or kcat and
completely abrogate argifin/argadin binding. This is in
agreement with the observation discussed earlier that
Phe251 is a key factor in tuning argadin affinity. Mu-
tations of Ala217 and Met243 have minor effects on Km,
but both reduce kcat by an order of magnitude (Table
2). These residues are highly conserved in family 18 chi-
tinases, and their close promixity to the C1 carbon of
the substrate may well give them some involvement in
stabilization of the transition state [17, 21, 30, 43]. The
Ala217Gly mutation appears to specifically affect bind-
ing to argifin (9-fold reduction in Kd), which is seen to
approach Ala217 with the terminal methyl group on the
guanyl-urea moiety (Figure 3). The Met243Ala mutant
mostly affects binding to argadin (12-fold reduction in
Kd), which directly contacts the Sδ atom of this side
chain through the face of the imidazole group of the
histidine side chain (Figure 4).
The last group of mutants, Thr138Ala and Glu322Ala,
involves residues that are not well conserved in family
18 chitinases. Both residues occupy a position toward
the nonreducing end edge of the active site (i.e., the
−2/−3 subsites) (Figures 3 and 4). Strikingly, mutation
of these residues to alanine appears to slightly
decrease Km, while not affecting kcat (Table 2). This is
surprising, as both these residues have been shown to
establish favorable contacts in a chitinase-substrate
complex [31] and chitinase-allosamidin complexes [17,
31], including the CiCTS1-allosamidin complex [15].
However, it is worth noting that both mutations show a
3- to 4-fold reduction in Kd for argifin/argadin, despite
the absence of specific interactions between these res-
idues and the inhibitors. This suggests that these resi-
dues, which are not conserved in the three chitinases
discussed here (Figures 3 and 4), could be worth ad-
dressing with argifin/argadin derivatives to increase se-
lectivity of these compounds.
Discussion
The data reported here provide further insights into how
two unusual natural product cyclopentapeptides inhibit
family 18 chitinases through mimicry of the carbohy-
drate substrate. Through a combination of hydrophobic
interactions and hydrogen bonding, argifin and argadin
occupy the −1, +1, and +2 subsites in the active site
groove of the chitinases. Although examples of struc-
tural carbohydrate mimicry through peptide molecules
has been reported previously, these have so far in-
volved inactive proteins (e.g., antibodies [44–46]) or gly-
cosidases bound to macromolecular inhibitors (e.g.,
amylase with a lectin-like inhibitor [47]). Argifin and ar-
gadin are the first examples of low-molecular-weight
peptide inhibitors that act on a carbohydrate-process-
ing enzyme.
There are a number of family 18 chitinases of the bac-
terial class whose function is not well understood, yet
there is evidence that they are interesting targets for
inhibition with selective compounds from a chemother-
apeutical perspective. These chitinases include those
from (parasitic) nematodes [48–51], protozoan parasites
[7–9], insects [52], and mammals [3, 10]. Although allo-samidin does inhibit this class of chitinases [12], it only
addresses the −1 (catalytic) subsite through its allo-
samizoline moiety and the −2/−3 subsites with the
N-acetyl allosamine sugars [13, 15–17, 30]. The struc-
tural and biochemical data presented here demonstrate
that the +1/+2 subsites, lined by two aromatics (Trp137
and Phe251 in AfChiB1; Figures 3 and 4), are, along
with the −1 subsite, the main determinants for argifin/
argadin affinity and selectivity. It should be noted that
the family 18 chitinases of the plant class have a signifi-
cantly smaller catalytic core and completely lack the
loops that carry these aromatic residues in the larger
bacterial-class chitinases. In the light of the chitinase-
argifin/argadin structures and mutagenesis presented
here, it is therefore likely that the plant-class family 18
chitinases are not inhibited by these cyclopentapep-
tides, whereas they are potently inhibited by allosami-
din [12, 13]. Indeed, initial inhibition tests with argadin
against SmChiC, a plant-class family 18 chitinase from
S. marcescens, have shown no significant inhibition at
up to 50 M concentration (V.G.H. Eijsink, personal
communication).
The comparison of the chitinase-argifin/argadin com-
plexes shows that although there is high sequence
conservation of the residues in the active site, and the
majority of protein-inhibitor contacts are made through
these residues, subtle changes in residues near the
active site can have significant effects. It should be
possible to exploit these subtle differences (e.g., the
residues at positions 138, 251, and 322 AfChiB1) to de-
sign argifin/argadin derivatives that specifically inhibit
a particular chitinase of the bacterial class. Such mole-
cules could be tools to study the complex functions
of chitinases in fungi, nematodes, protozoan parasites,
insects, and mammals. Total synthesis of argifin and
argadin is currently being explored to overcome the
limited availability of these compounds from natural
sources, and we hope to report on the design and syn-
thesis of such derivatives in the near future.
Significance
Family 18 chitinases are enzymes that hydrolyze the
glycosidic bonds of chitin, a polymer of (1,4)-linked
N-acetyl glucosamine, which is found as a compo-
nent of the fungal cell wall, insect exoskeleton, and
nematode egg shell. Inhibitors of these enzymes are
of considerable interest as research tools but also
may have chemotherapeutic potential against patho-
genic fungi, insects, and nematodes. Here, we show
how two natural product cyclopentapeptides, argifin
and argadin, inhibit chitinases by binding to the active
site, mimicking interactions that these enzymes make
with their natural substrate, chitin. The crystal struc-
tures of complexes of chitinases with argifin/argadin
together with binding studies on a range of mutants
show how these remarkable peptides mimic the shape,
hydrogen bonding patterns, and hydrophobic stack-
ing of the substrate. There appear to be interesting
differences in the details of these interactions be-
tween a chitinase from the fungal pathogen Aspergil-
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74flus fumigatus and a human chitinase, which may al-
(low the development of specific inhibitors.
m
Experimental Procedures B
c
Cloning g
A fragment corresponding to AfChiB1 was amplified by PCR from i
the previously described gene [53] (GeneBank accession no. o
AY217660) in pPICZαA as a template (forward primer, 5#-GGATC l
CAGCTCCGGTTATCGCTCGGTC-3#; reverse primer, 5#-CCTAGGTT m
AGGTTTGCATGCCATTGCGCAG-3#). The PCR product was ligated a
into pCR 2.1-TOPO (Invitrogen) and subcloned into the pGEX-6P-1 o
vector (Amersham) using the BamH1 and EcoR1 restriction sites m
(indicated in bold above). Single amino acid residue changes were
made using the Quick Change Site Directed Mutagenesis Kit (Stra- s
tagene) following the manufacturer’s instructions. All plasmids r
were verified by DNA sequencing (The Sequencing Service, School w
of Life Sciences, University of Dundee, Scotland, UK). t
3
wExpression and Purification
dThe AfChiB1-pGEX-6P-1 construct was transformed into E. coli
tBL21(DE3) pLysS cells. Cells were grown overnight in Luria-Bertani
cmedium (LB)+ ampicillin (100 g/ml). From this culture, 10 ml of
cells were used to inoculate 1 liter of LB media. The cells were
ugrown to OD600 = 0.5 before protein expression was induced by the
Iaddition of 250 M isopropyl-β-D-thiogalactopyranoside, and then
nthe cells were cultured for an additional 4 hr at 37°C. The cells were
harvested by centrifugation at 2500 g for 30 min, flash frozen in
liquid nitrogen, thawed at 37°C, and resuspended in 25 ml of lysis E
buffer (50 mM HEPES, 250 mM NaCl [pH 7.5]) and half a “Com- B
plete” protease inhibitor tablet (Roche). Lysis was achieved by the b
addition of 20 l DNase (Roche) (10 u/l) and approximately 13 mg F
lysozyme (Sigma) incubating for 10 min on ice, followed by 4 × 30 E
s sonication. The lysate was centrifuged at 18,900 g for 30 min and s
passed through a 0.45 m filter. The filtrate was then incubated at r
4°C on a rotating platform with 2 ml glutathione-Sepharose beads a
(Amersham) prewashed with lysis buffer for 2 hr. The N-terminal a
GST tag was removed from the GST-AfChiB1 fusion protein by in- S
cubating the beads with PreScission Protease (50 g) at 4°C for 18 s
hr. The supernatant of the beads and a subsequent wash were o
filtered to remove traces of beads, concentrated to 4 ml, and h
loaded onto a Superdex 75, 26/60 gel filtration column preequili- (
brated in buffer (25 mM HEPES, 250 mM NaCl [pH 7.5]). The pure s
fractions were verified by SDS-PAGE and pooled and then dialyzed m
overnight into 50 mM Tris (pH 8.0) at 4°C. g
g
sCrystallization and Structure Determination
Pure AfChiB1 protein was spin concentrated to 28 mg/ml. Vapor i
gdiffusion crystallization experiments were set up by mixing 1 l of
protein and 1 l of mother liquor consisting of 0.1 M Tris/HCl (pH
w9.5) and 1.4 M Li2SO4 and equilibrated against a reservoir contain-
ing 0.5 ml of mother liquor. Rod-shaped crystals appeared after 3 f
rdays growing to a maximum size of 0.3 × 0.1 × 0.1 mm. Crystals
used for soaking experiments were washed three times in 0.1 M 5
csodium citrate (pH 5.5) and 1.4 M Li2SO4, with the final drop con-
taining approximately 60-fold molar excess of ligand, using 30 min o
wsoaking time. The crystals were cryoprotected by a 10 s immersion
in 3 M Li2SO4 and then frozen in a nitrogen cryostream for data col- g
ulection.
Human chitotriosidase was purified and prepared for crystalliza- c
stion as described previously [3, 28, 54]. Hanging drop vapor diffu-
sion in 1 ml wells was used to cocrystallise complexes of HCHT o
pwith argifin and argadin. Plate-shaped crystals formed of approxi-
mate dimensions 0.2 × 0.2 × 0.05 mm in a 1 l drop containing 4 d
mmg/ml HCHT, 100-fold excess ligand, 10% isopropanol, 10% PEG
4000, and 0.05 M sodium citrate (pH 5.6). The crystals were trans- c
ferred to a 0.25 l drop of mother liquor in which the concentration
of isopropanol had been increased to 50% for cryoprotection be- d
Dfore freezing in a 100 K nitrogen cryostream.
Data were collected on beamline BM14 at the European Syn- i
vchrotron Radiation Facility (Grenoble, France) and beamline X11 at
the Deutsches Elektronen Synchrotron (Hamburg, Germany). Dif- wraction data were processed with the HKL suite of programs [55]
Table S1).
The native AfChiB1 structure was solved by molecular replace-
ent with AMoRe [56] using the C. immitis chitinase 1 (Protein Data
ank [PDB] code 1D2K) as a search model [27]. With two mole-
ules in the asymmetric unit, a clear solution was obtained, which
ave an R factor of 0.27 with 3.0 Å data after rigid body refinement
n CNS [57]. This was used as a starting structure for the refinement
f the other complexes. The HCHT-argifin complex, which crystal-
ized in a different space group from native HCHT, was solved by
olecular replacement with AMoRe [56] using the native structure
s a search model (PDB code 1GUV [28]). A clear solution was
btained (R = 0.323, correlation coefficient = 71.6) for a single
olecule in the asymmetric unit.
All refinement was initiated by rigid body refinement, followed by
imulated annealing with CNS [57], followed by iterative cycles of
efinement and model binding in O [58]. Models for the ligands
ere not included until their conformations were well defined by
he unbiased rFor − rFcr, fcalc electron density maps (Figures 2B,
, and 4). Ligand starting structures and topologies were generated
ith PRODRG [59]. Further refinement resulted in the final models
escribed in Table S1. In the interest of simplicity, differences be-
ween the complexes are discussed using the first monomer in the
oordinate files.
Structural superpositions were performed with the MOTIF mod-
le of WHAT IF [60] and LSQKAB from the CCP4 package [61].
mages were generated with PYMOL (http://pymol.sourceforge.
et/).
nzymology
inding of ligands to wild-type and mutant AfChiB1 was analyzed
y ligand-induced quenching of intrinsic tryptophan fluorescence.
luorescence measurements were carried out with a Varian Cary
clipse fluorescence spectrophotometer equipped with a thermo-
tatted cuvette holder equilibrated at 25°C. Emission spectra were
ecorded from 330–360 nm upon excitation at 295 nm. Excitation
nd emission slits were opened to 10 nm and 20 nm, respectively,
nd the spectra were recorded at a scan speed of 9–60 nm/min.
tandard reaction mixtures contained 0.5 M of AfChiB1 in 50 mM
odium citrate, 250 mM sodium chloride (pH 5.5) to a final volume
f 1 ml. After preincubation for 10 min at 25°C within the cuvette
older, aliquots of argifin or argadin were added to the mixture
final volume did not exceed 5% of the total volume). The emission
pectrum was recorded after each addition following mixing and 5
in incubation. All of the spectra were corrected for the back-
round emission signal from both the buffer and the unbound li-
and and repeated in triplicate. The equilibrium dissociation con-
tant could be obtained from fitting the fractional fluorescence
ntensity data to a single site binding equation using nonlinear re-
ression analysis with the software GraFit [62].
Michaelis-Menten parameters of wild-type and mutant AfChiB1
ere determined using the fluorogenic substrate 4-methylumbelli-
eryl β-D-N,N#-diacetylchitobiose (4MU-NAG2; Sigma). Standard
eaction mixtures contained 2 nM of AfChiB1, 0.1 mg/ml BSA, and
–40 M of the fluorogenic substrate in McIlvain buffer (100 mM
itric acid, 200 mM sodium phosphate [pH 5.5]) to a final volume
f 50 l. Reaction mixtures were incubated for 10 min at 37°C, after
hich the reaction was stopped with the addition of 25 l of 3 M
lycine-NaOH (pH 10.3). The fluorescence of the released 4-methyl-
mbelliferone was quantified using a Flx 800 microtitreplate fluores-
ence reader (Bio-Tek Instruments Inc.) (excitation 366 nm, emis-
ion 445 nm). Experiments were performed in triplicate. Production
f 4-methylumbelliferone was linear with time for the incubation
eriod used, and less than 10% of available substrate was hy-
rolyzed. The IC50s of argifin/argadin against AfChiB1 were deter-
ined using the same protocol but with a constant substrate con-
entration of 20 M and 0.01–100 M inhibitor.
The IC50s of argifin/argadin against the human chitinase were
etermined using the fluorogenic substrate 4-methylumbelliferyl-β-
-N,N#,N##-triacetylchitotriose (4MU-NAG3, Sigma, St Louis, MO)
n a standard assay, as previously described [3]. Briefly, in a final
olume of 125 l, a constant amount of enzyme was incubated
ith 0.022 mM substrate in McIlvain buffer (adjusted to pH 5.2)
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75containing 1 mg/ml BSA for 20 min at 37°C in the presence of dif-
ferent concentrations of inhibitor. After addition of 2.5 ml 0.3 M
glycine-NaOH (pH 10.6), the fluorescence of the liberated 4MU was
quantified using a Perkin Elmer LS2 fluorimeter (excitation 366 nm,
emission 445 nm). The ability of chitotriosidase to transglycosylate
does not allow determination of Ki values [63].
Supplemental Data
A table with details of data collection and structure refinement is
available online at http://www.chembiol.com/cgi/content/full/12/1/
65/DC1/.
Accession Numbers
The coordinates and structure factors have been deposited in the
PDB under ID codes 1W9P (native AfChiB1), 1WAV (AfChiB1 + ar-
gadin), 1W9V (AfChiB1 + argifin), 1WAW (HCHT + argadin), and
1WB0 (HCHT + argifin).
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